45 CFR § 180 compliance
D · 65
This hospital published part of what § 180 requires.
●Machine-readable file published
●Gross / standard charges
●Discounted cash price
○Payer-specific negotiated rates
○Min / max negotiated charges
●Free, public, no login required
Procedures listed
35,004
Insurances with rates
22
CPT / HCPCS codes
2,299
Source MRF
Most expensive procedures (gross)
| Code | Description | Gross | Cash | Min payer | Max payer | # insurers |
|---|---|---|---|---|---|---|
| J0225 | INJ, VUTRISIRAN, 1 MG | $393,916 | $256,046 | — | — | 0 |
| A9513 | LUTETIUM LU 177 DOTATAT THER | $221,304 | $143,848 | — | — | 0 |
| 4080070058216722433800500821672CAH INJECTABLE HAZARDOUS MEDICATION [68] | CARMUSTINE IN POLIFEPROSAN 7.7 MG IMPL WAFR | $188,198 | $122,329 | — | — | 7 |
| 4080070058216722433800500821672INJECTABLE HAZARDOUS MEDICATION [44] | CARMUSTINE IN POLIFEPROSAN 7.7 MG IMPL WAFR | $188,198 | $122,329 | — | — | 7 |
| 4080030127216722433800500821672CAH INJECTABLE HAZARDOUS MEDICATION [68] | CARMUSTINE IN POLIFEPROSAN 7.7 MG IMPL WAFR | $188,198 | $122,329 | — | — | 7 |
| 4080030127216722433800500821672INJECTABLE HAZARDOUS MEDICATION [44] | CARMUSTINE IN POLIFEPROSAN 7.7 MG IMPL WAFR | $188,198 | $122,329 | — | — | 7 |
| A9607 | LUTETIUM LU 177 VIPIVOTIDE | $168,913 | $109,793 | — | — | 0 |
| A9606 | RADIUM RA223 DICHLORIDE THER | $140,725 | $91,471 | — | — | 0 |
| A9699 | RADIOPHARM RX AGENT NOC | $140,308 | $91,200 | — | — | 0 |
| J9266 | PEGASPARGASE INJECTION | $125,524 | $81,590 | — | — | 0 |
| J2507 | PEGLOTICASE INJECTION | $104,959 | $68,224 | — | — | 0 |
| J0223 | INJ GIVOSIRAN 0.5 MG | $94,660 | $61,529 | — | — | 0 |
| J2351 | INJ OCRELIZUMAB 1MG HYA-OCSQ | $93,659 | $60,879 | — | — | 0 |
| 59572-0775-01 | Reblozyl | $92,751 | $60,288 | — | — | 0 |
| 0310-4535-30 | Imjudo | $91,495 | $59,472 | — | — | 0 |
| 0003-2328-22 | Yervoy | $79,716 | $51,815 | — | — | 0 |
| C2616 | BRACHYTX, NON-STR,YTTRIUM-90 | $73,655 | $47,876 | — | — | 0 |
| J9334 | INJ EFGART-ALFA 2MG HYA-QVFC | $73,256 | $47,616 | — | — | 0 |
| J9307 | PRALATREXATE INJECTION | $69,509 | $45,181 | — | — | 0 |
| 00003-7125-11 | Opdualag | $66,603 | $43,292 | — | — | 0 |
| 00003-2328-22 | Yervoy | $66,043 | $42,928 | — | — | 0 |
| J9298 | INJECTION; NIVOLUMAB AND RELATLIMAB-RMBW; 3 MG/1 MG | $64,652 | $42,024 | — | — | 0 |
| J0202 | INJECTION, ALEMTUZUMAB | $64,238 | $41,755 | — | — | 0 |
| J3357 | USTEKINUMAB SUB CU INJ, 1 MG | $64,123 | $41,680 | — | — | 0 |
| J7311 | INJ., RETISERT, 0.01 MG | $62,841 | $40,846 | — | — | 0 |
| 68727-0712-01 | Zepzelca | $58,970 | $38,331 | — | — | 0 |
| J1290 | ECALLANTIDE INJECTION | $53,230 | $34,599 | — | — | 0 |
| 0078-0734-61 | Ilaris | $48,494 | $31,521 | — | — | 0 |
| J3590 | UNCLASSIFIED BIOLOGICS | $44,396 | $28,858 | — | — | 0 |
| 50242-0103-01 | Polivy | $43,004 | $27,952 | — | — | 0 |
| J9301 | OBINUTUZUMAB INJ | $42,284 | $27,485 | — | — | 0 |
| J9043 | INJECTION; CABAZITAXEL; 1 MG | $41,778 | $27,156 | — | — | 0 |
| J7214 | ALTUVIIIO PER FACTOR VIII IU | $40,559 | $26,364 | — | — | 0 |
| J3241 | INJ. TEPROTUMUMAB-TRBW 10 MG | $40,540 | $26,351 | — | — | 0 |
| J2327 | INJECTION; RISANKIZUMAB-RZAA; INTRAVENOUS; 1 MG | $40,309 | $26,201 | — | — | 0 |
| J7202 | FACTOR IX IDELVION INJ | $40,080 | $26,052 | — | — | 0 |
| J0896 | INJECTION; LUSPATERCEPT-AAMT; 0.25 MG | $39,455 | $25,646 | — | — | 1 |
| J9223 | INJ. LURBINECTEDIN, 0.1 MG | $37,655 | $24,475 | — | — | 1 |
| J7170 | INJ., EMICIZUMAB-KXWH 0.5 MG | $36,960 | $24,024 | — | — | 0 |
| J9319 | INJECTION; ROMIDEPSIN; LYOPHILIZED; 0.1 MG | $35,985 | $23,390 | — | — | 0 |
| J9205 | INJECTION; IRINOTECAN LIPOSOME; 1 MG | $35,046 | $22,780 | — | — | 0 |
| 15054-0043-01 | Onivyde | $35,046 | $22,780 | — | — | 0 |
| 0003-7125-11 | Opdualag | $34,108 | $22,170 | — | — | 0 |
| J9026 | INJ, TARLATAMAB-DLLE, 1 MG | $33,506 | $21,779 | — | — | 0 |
| J9299 | INJECTION; NIVOLUMAB; 1 MG | $33,439 | $21,735 | — | — | 3 |
| 00003-3734-13 | Opdivo | $33,439 | $21,735 | — | — | 0 |
| 26123 | REMOVAL OF CONNECTIVE TISSUE OF PALM AND RELEASE OF FINGER; FIRST DIGIT | $32,750 | $21,288 | — | — | 0 |
| J0584 | INJECTION, BUROSUMAB-TWZA 1M | $31,967 | $20,778 | — | — | 0 |
| 77372 | COMPLETE SINGLE SESSION COURSE OF CRANIAL LESION SURGERY USING RADIATION AND A MACHINE TO DELIVER EX | $30,960 | $20,124 | — | — | 1 |
| 50242-0245-01 | Phesgo | $30,280 | $19,682 | — | — | 0 |
Showing top 50 of 35,004 priced procedures, sorted by gross charge.
Data straight from this hospital's federally-mandated machine-readable file (45 CFR § 180). The compliance grade reflects how completely the hospital published the six required data elements, not the quality of care.